*All other brand or product names located in this site are Trademarks of their respective holders.
Lenalidomide Capsules
New product launched on April 25, 2023.
NDC Number :
60505-4536-02
Material Number :
67157
Active Ingredient :
Lenalidomide
Bioequivalent to * :
REVLIMID®
Therapeutic Class (AHFS) :
Antineoplastic Agents
Strength :
20MG
Pack Size (Form) :
21 CAPSULE (BOTTLE)
Dosage Form :
Capsule
Scored :
N/A
Color :
Powder blue opaque body and blue green opaque cap
Shape :
Hard gelatin capsule
Markings :
Imprinted "APO L20"
Route of Administration :
Oral
Storage Condition :
Controlled Room Temperature (68 - 77 degrees F)
Minimum Order Quantity :
1
Multiple Order Quantity :
1
Latex Free :
Yes
Sugar Free :
Yes
Dye Free :
No
Alcohol Free :
Yes
Preservative Free :
Yes
Hazardous Material :
Yes
Product Resources :
Prescribing Information (1361 KB)
Medication Guide (57 KB)
photo not available
Packaging Information :
Length | Width | Height | Weight | Units/Pack | |
---|---|---|---|---|---|
Unit | 1.8 in | 1.8 in | 3 in | 0.08 lb | N/A |
Inner | 7.1 in | 5.3 in | 3 in | 0.91 lb | 6 |
Case | 11.7 in | 8.1 in | 9.3 in | 5.98 lb | 36 |